John Robert Wilson

CIK 1755569 · last filed 2023-06-08

John Robert Wilson is a corporate insider who has filed 10 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for MRKR, was dated Jun 8, 2023. Across all open-market trades the lifetime net is −$3.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $921.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$921.8K

Companies

2

Total Filings

10

Lifetime Open-Market Net

-$3.27M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MRKR Director 781,201 $1.18 $921.8K $3.00M 6 2023-06-08
Kalaris Therapeutics, Inc. (ALVR) Delisted Director 235,346 $9.81 $2.31M -$6.27M 4 2021-05-27

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-08 MRKR Grant (A) $0 EDGAR
2022-05-26 MRKR Grant (A) $0 EDGAR
2021-06-10 MRKR Grant (A) +12,658 $0 EDGAR
2021-05-27 Kalaris Therapeutics, Inc. (ALVR) Delisted Grant (A) $0 EDGAR
2021-03-18 MRKR Buy (P) +1,714,285 $3.00M EDGAR
2021-03-11 Kalaris Therapeutics, Inc. (ALVR) Delisted Sell (S) −200,002 -$6.27M EDGAR
2020-08-06 Kalaris Therapeutics, Inc. (ALVR) Delisted Conv (C) +5,532,757 $0 EDGAR
2020-07-31 Kalaris Therapeutics, Inc. (ALVR) Delisted Grant (A) $0 EDGAR
2019-05-13 MRKR Grant (A) +7,260 $0 EDGAR
2018-10-19 MRKR Grant (A) $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.